Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intra-atrial defibrillation--limits and possibilities]

W Jung1, B Lüderitz

  • 1Medizinische Universitätsklinik und Poliklinik Bonn.

Zeitschrift Fur Kardiologie
|January 1, 1996
PubMed
Summary

Intraatrial defibrillation offers a safe and effective alternative to external cardioversion for atrial fibrillation termination. This low-energy method is particularly beneficial for patients resistant to conventional treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of obstructive sleep apnea on heart rate turbulence.

Basic research in cardiology·2005
Same author

[Postoperative arrhythmias].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

[Atrial fibrillation -- interventional therapy with respect to age].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein.

Heart (British Cardiac Society)·2005
Same author

Atrial fibrillation: profit from cardiac pacing?

Zeitschrift fur Kardiologie·2005
Same author

[Progressive upper lobe consolidation in a 73-year old healthy woman].

Der Internist·2005

Area of Science:

  • Cardiology
  • Electrophysiology

Context:

  • External cardioversion for atrial fibrillation requires general anesthesia and high energy.
  • Intraatrial defibrillation has been explored as a lower-energy alternative for over two decades.
  • Key considerations include efficacy, safety, patient acceptance, atrial stunning, thromboembolism risk, and anticoagulation.

Purpose:

  • To evaluate the efficacy and safety of intraatrial defibrillation for terminating atrial fibrillation.
  • To assess patient acceptance and potential proarrhythmic effects of intraatrial defibrillation.
  • To investigate the impact of intraatrial defibrillation on left atrial appendage flow.

Summary:

  • Intraatrial defibrillation is a safe and effective method for terminating atrial fibrillation, especially in patients refractory to external cardioversion.
  • The mean defibrillation threshold was low (9.1 J), with minimal proarrhythmic events observed.
  • Moderate discomfort was reported, and temporary reductions in left atrial appendage flow were noted, recovering within seven days.
  • The first atrial defibrillator implantation in Germany occurred in 1996 for drug-refractory atrial fibrillation.

Impact:

  • Intraatrial defibrillation provides a viable, lower-energy option for atrial fibrillation management.
  • Implantable atrial defibrillators represent a significant advancement for refractory atrial fibrillation cases.
  • Further research can optimize intraatrial defibrillation protocols and device development.

Related Experiment Videos